LT3205334T - Būdas ir kompozicija, skirti akių hipertenzijai ir glaukomai gydyti - Google Patents

Būdas ir kompozicija, skirti akių hipertenzijai ir glaukomai gydyti

Info

Publication number: LT3205334T
Authority: LT; Lithuania
Prior art keywords: promotion; treatment; composition; eye hypertension; hypertension
Prior art date: 2008-05-30

Application number

LTEP17000440.2T

Other languages

English (en)

Inventor

Timo Reunamaki

Pertti Pellinen

Olli Oksala

Kari Lehmussaari

Original Assignee

Santen Pharmaceutical Co., Ltd.

AGC Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-05-30

Filing date

2009-05-28

Publication date

2020-09-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39940592&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT3205334(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-05-28 Application filed by Santen Pharmaceutical Co., Ltd., AGC Inc. filed Critical Santen Pharmaceutical Co., Ltd.

2020-09-25 Publication of LT3205334T publication Critical patent/LT3205334T/lt

Links

206010020772 Hypertension Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Oil, Petroleum & Natural Gas (AREA)
Ophthalmology & Optometry (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

LTEP17000440.2T 2008-05-30 2009-05-28 Būdas ir kompozicija, skirti akių hipertenzijai ir glaukomai gydyti LT3205334T (lt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP08397513A EP2127638A1 (en)	2008-05-30	2008-05-30	Method and composition for treating ocular hypertension and glaucoma

Publications (1)

Publication Number	Publication Date
LT3205334T true LT3205334T (lt)	2020-09-25

Family

ID=39940592

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
LTEP17000440.2T LT3205334T (lt)	2008-05-30	2009-05-28	Būdas ir kompozicija, skirti akių hipertenzijai ir glaukomai gydyti
LTEP20164602.3T LT3714877T (lt)	2008-05-30	2009-05-28	Būdas ir kompozicija, skirti akių hipertenzijai ir glaukomai gydyti
LTEP14001862.3T LT2772249T (lt)	2008-05-30	2009-05-28	Būdas ir kompozicija, skirti akių hipertenzijos ir glaukomos gydymui

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
LTEP20164602.3T LT3714877T (lt)	2008-05-30	2009-05-28	Būdas ir kompozicija, skirti akių hipertenzijai ir glaukomai gydyti
LTEP14001862.3T LT2772249T (lt)	2008-05-30	2009-05-28	Būdas ir kompozicija, skirti akių hipertenzijos ir glaukomos gydymui

Country Status (27)

Country	Link
US (3)	US9999593B2 (lt)
EP (8)	EP2127638A1 (lt)
JP (9)	JP2011521943A (lt)
KR (5)	KR102246598B1 (lt)
CN (1)	CN102083413B (lt)
AR (2)	AR071937A1 (lt)
AU (1)	AU2009252210C1 (lt)
BR (1)	BRPI0913109B8 (lt)
CA (2)	CA2724194C (lt)
CY (2)	CY1115565T1 (lt)
DK (4)	DK2772249T3 (lt)
EA (1)	EA023661B1 (lt)
ES (7)	ES2495316T3 (lt)
GE (1)	GEP20156220B (lt)
HR (4)	HRP20220361T1 (lt)
HU (3)	HUE049923T2 (lt)
JO (1)	JO3039B1 (lt)
LT (3)	LT3205334T (lt)
MX (1)	MX2010012987A (lt)
MY (1)	MY159463A (lt)
PL (4)	PL3205334T3 (lt)
PT (4)	PT3714877T (lt)
SG (1)	SG191628A1 (lt)
SI (4)	SI2772249T1 (lt)
TW (1)	TWI432202B (lt)
UA (1)	UA102257C2 (lt)
WO (1)	WO2009145356A1 (lt)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI544927B (zh)	2008-03-17	2016-08-11	愛爾康研究有限公司	具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物
EP2127638A1 (en)	2008-05-30	2009-12-02	Santen Pharmaceutical Co., Ltd	Method and composition for treating ocular hypertension and glaucoma
EP2228058A1 (en)	2009-03-04	2010-09-15	Novagali Pharma S.A.	Anionic oil-in-water emulsion containing prostaglandins and uses thereof
EP2389939A1 (en)	2010-05-28	2011-11-30	Novagali Pharma S.A.	Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
US20110136872A1 (en) *	2009-12-09	2011-06-09	Burk Robert M	Stable aqueous compositions of prostglandin agonist prodrugs and methods for use thereof
JP5681472B2 (ja) *	2009-12-28	2015-03-11	ロート製薬株式会社	眼科用組成物
FR2961694B1 (fr) *	2010-06-29	2013-01-25	Thea Lab	Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur
US10154923B2 (en) *	2010-07-15	2018-12-18	Eyenovia, Inc.	Drop generating device
US9061034B2 (en) *	2010-07-29	2015-06-23	Allergan, Inc.	Preservative free bimatoprost and timolol solutions
AU2011282679A1 (en) *	2010-07-29	2013-03-07	Allergan, Inc.	Preservative free bimatoprost solutions
HUE059325T2 (hu) *	2010-07-29	2022-11-28	Allergan Inc	Tartósítószer-mentes bimatoprost és timolol oldatok
WO2012021107A2 (en)	2010-08-12	2012-02-16	Nanyang Technological University	A liposomal formulation for ocular drug delivery
ES2616089T3 (es) *	2010-09-21	2017-06-09	S & V Technologies Gmbh	Composición cosmética
EP2452669A1 (en) *	2010-10-29	2012-05-16	Omnivision GmbH	Ophthalmic composition
CN103596572A (zh) *	2011-04-12	2014-02-19	株式会社·R-技术上野	水性眼用组合物
CN102716074B (zh) *	2012-06-28	2013-10-16	武汉武药科技有限公司	一种贝美前列素滴眼剂及其制备方法
PL2887923T3 (pl)	2012-08-24	2023-08-14	Sun Pharmaceutical Industries Limited	Preparat okulistyczny polioksylipidu lub polioksylowego kwasu tłuszczowego i leczenie chorób oczu
US9956195B2 (en)	2014-01-07	2018-05-01	Nanyang Technological University	Stable liposomal formulations for ocular drug delivery
WO2015106068A1 (en)	2014-01-10	2015-07-16	Manistee Partners Llc	Treatment of migraines
CN104766952B (zh) *	2015-04-21	2017-01-25	武汉凯迪工程技术研究总院有限公司	利用生物质气化炉滤渣制备锂离子电池负极材料的方法
ES2747302T3 (es)	2015-06-09	2020-03-10	Medproject Pharma Entw Und Vertriebsgesellschaft Mbh	Gel oftálmico de bimatoprost aplicable en gotas
US10105371B2 (en) *	2015-10-09	2018-10-23	Tamara Vrabec	Use of medications with neuroprotective properties to prevent or reduce the risk of ischemia-reperfusion injury in a subject
EP3370709A4 (en) *	2015-11-06	2019-12-18	Accuitis Pharmaceuticals, Inc.	USE OF PROTEASOME INHIBITORS FOR THE TREATMENT OF EYE DISEASES
DK3373976T3 (da)	2015-11-10	2024-04-02	Sun Pharmaceutical Ind Ltd	Topiske formuleringer og anvendelser deraf
NZ785158A (en)	2016-02-29	2025-03-28	Sun Pharmaceutical Ind Ltd	Topical cyclosporine-containing formulations and uses thereof
GR1009040B (el) *	2016-04-19	2017-05-19	Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων	Φαρμακευτικο οφθαλμικο σκευασμα ελευθερο συντηρητικου
WO2018033854A1 (en) *	2016-08-15	2018-02-22	Santen Pharmaceutical Co., Ltd.	Ophthalmic composition and a method for treating ocular hypertension and glaucoma
KR101770324B1 (ko) *	2016-11-09	2017-08-22	주식회사태준제약	안압 강하용 점안 조성물
JP2020059652A (ja) *	2016-12-26	2020-04-16	参天製薬株式会社	タフルプロストとクエン酸エステルとを含有するデポ剤
EP3603642B1 (en) *	2017-03-27	2024-01-10	Alcon Inc.	Pharmaceutical preparation
US20180318319A1 (en) *	2017-05-04	2018-11-08	Ocular Science, Inc.	Compositions and Methods for Treating Eyes and Methods of Preparation
WO2018236158A1 (ko)	2017-06-22	2018-12-27	연성정밀화학(주)	녹내장 치료용 점안 조성물
EP3730138B1 (en) *	2017-12-21	2024-02-14	Santen Pharmaceutical Co., Ltd.	Combination of sepetaprost and ripasudil for use in the prophylaxis or treatment of glaucoma or ocular hypertension
US12263119B2 (en)	2018-07-09	2025-04-01	Zaklady Farmaceutyczne Polpharma S.A.	Opthalmic dispensing device
JP7599838B2 (ja) *	2019-04-10	2024-12-16	参天製薬株式会社	エピナスチン又はその塩を含有する水性医薬組成物
CN111632025A (zh) *	2020-03-04	2020-09-08	吉林大学第一医院	一种贝美前列素眼用温度敏感型原位凝胶及其制备方法与应用
CN111840225B (zh) *	2020-08-12	2021-09-14	陈丽娜	一种用于治疗青光眼的滴眼剂及其制备方法
RU2761625C2 (ru) *	2021-02-11	2021-12-13	Общество с ограниченной ответственностью "Гротекс" (ООО "Гротекс")	Фармацевтическая композиция тафлупроста
CN116687842A (zh) *	2022-02-28	2023-09-05	山东新时代药业有限公司	一种拉坦前列素滴眼液及其制备方法
AU2023240729A1 (en) *	2022-03-25	2024-10-03	Tsubota Laboratory, Inc.	Aqueous composition
WO2023241652A1 (zh) *	2022-06-16	2023-12-21	广州润尔眼科生物科技有限公司	一种药物组合物及其制备方法和应用
WO2024203727A1 (ja) *	2023-03-24	2024-10-03	株式会社坪田ラボ	水性組成物
WO2024232425A1 (ja) *	2023-05-11	2024-11-14	テイカ製薬株式会社	プロスタグランジンＦ２α誘導体の含有率低下が抑制されている製品
JP7757564B1 (ja)	2024-06-28	2025-10-21	東亜薬品株式会社	水性組成物
GR1011143B (el) *	2025-04-11	2026-03-02	Ιουλια Τσετη	Οφθαλμικο διαλυμα προσταγλανδινης χωρις συντηρητικα

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4778815A (en) *	1987-03-18	1988-10-18	Ciba-Geigy Corporation	Method of inhibiting cataracts by topical application of a 2-substituted 1,2-benzisoselenazol-3(2H)-one
ATE76750T1 (de)	1987-04-03	1992-06-15	Univ Columbia	Anwendung eines prostaglandins in mischung mit einem adrenergischen blocker zur verminderung des augen-innendruckes.
US5409125A (en)	1989-12-11	1995-04-25	Aktiebolaget Astra	Unit dose container
DE4027320C2 (de)	1990-08-29	1993-09-30	Ursapharm Arzneimittel Gmbh	Fluid-Abgabeeinrichtung für keimfreies Fluid
JPH0655640A (ja)	1992-08-04	1994-03-01	Aavan Internatl:Kk	洗面台カウンター及びその製造方法
JPH06107547A (ja)	1992-10-01	1994-04-19	Aarutetsuku Ueno:Kk	眼科用組成物
AU665287B2 (en)	1992-12-21	1995-12-21	Alcon Laboratories, Inc.	Prostaglandin combinations in glaucoma therapy
JP2510066Y2 (ja)	1993-01-20	1996-09-11	東洋製罐株式会社	加熱殺菌可能な液体医薬容器
US5807892A (en)	1994-09-30	1998-09-15	Alcon Laboratories, Inc.	Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
US5631287A (en)	1994-12-22	1997-05-20	Alcon Laboratories, Inc.	Storage-stable prostaglandin compositions
CA2237898A1 (en) *	1995-11-17	1997-05-29	Louis Desantis Jr.	Combination therapy for treating glaucoma
EP0930296B2 (en)	1996-09-17	2005-11-02	Asahi Glass Company Ltd.	Fluorinated prostaglandin derivatives and medicines
CA2273837C (en)	1996-12-09	2003-12-30	Bausch & Lomb Incorporated	Single-use flexible container
JP3480549B2 (ja)	1996-12-26	2003-12-22	参天製薬株式会社	ジフルオロプロスタグランジン誘導体およびその用途
AR002194A1 (es)	1997-03-17	1998-01-07	Sanchez Reynaldo Alemany	Instrumento computarizado para el analisis del movimiento.
CA2274708A1 (en) *	1997-10-13	1999-04-22	R-Tech Ueno, Ltd.	Remedial composition for intraocular hypertension or glaucoma
US6066671A (en)	1997-12-19	2000-05-23	Alcon Laboratories, Inc.	Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides
GB2337740B (en)	1998-05-26	2000-11-15	Spreckelsen Mcgeough Ltd	Fluid packaging
US6235781B1 (en)	1998-07-14	2001-05-22	Alcon Laboratories, Inc.	Prostaglandin product
CA2295512C (en)	1998-07-14	2009-05-26	Alcon Laboratories, Inc.	Prostaglandin product
WO2000018316A2 (en)	1998-09-25	2000-04-06	Alcon Laboratories, Inc.	Sustained release, and comfortable ophthalmic composition and method for ocular therapy
US6096783A (en)	1998-12-15	2000-08-01	Alcon Laboratories, Inc.	Cyclobutane prostaglandin analogues as ocular hypotensive agents
AU2183900A (en)	1998-12-24	2000-07-31	Alcon Laboratories, Inc.	Ep4 receptor agonists for treatment of dry eye
CA2368083A1 (en)	1999-04-06	2000-10-12	Sepracor Inc.	Derivatives of venlafaxine and methods of preparing and using the same
EP1312380B1 (en)	2000-06-19	2006-05-03	Santen Pharmaceutical Co., Ltd.	Aseptics
JP3876355B2 (ja)	2000-09-13	2007-01-31	参天製薬株式会社	点眼液
PT1321144E (pt)	2000-09-13	2011-03-10	Santen Pharmaceutical Co Ltd	Colírio
TW586946B (en)	2000-12-22	2004-05-11	Novartis Ag	Process to improve stability
WO2004006826A1 (ja)	2002-07-16	2004-01-22	Senju Pharmaceutical Co., Ltd.	薬液容器及びその製造方法
CA2498233C (en)	2002-09-09	2012-08-14	Santen Pharmaceutical Co., Ltd.	Clear ophthalmic solution comprising latanoprost as active ingredient
US7074827B2 (en) *	2002-10-24	2006-07-11	Sucampo Ag (Usa) Inc.	Method for treating ocular hypertension and glaucoma
US20060199863A1 (en) *	2003-07-31	2006-09-07	Santen Pharmaceutical Co., Ltd.	Product containing prostaglandin
US20050287325A1 (en)	2004-06-25	2005-12-29	Pharmacia & Upjohn Company	Pharmaceutical containers with low adsorption/absorption of active ingredients, and a method of testing materials for adsorption/absorption of active ingredients
EP1655021B1 (en) *	2004-11-09	2008-10-29	Novagali Pharma SA	Oil-in-water type emulsion with low concentration of cationic agent and positive zeta potential
US7562796B2 (en)	2004-11-24	2009-07-21	Holopack International Corp.	Dispensing container with flow control system
CA2590277C (en)	2004-12-09	2014-07-08	Santen Pharmaceutical Co., Ltd.	Product containing prostaglandin having fluorine atom in its molecule
DK1829545T3 (da)	2004-12-24	2012-07-23	Santen Pharmaceutical Co Ltd	Produkter indeholdende prostaglandin-F2alfa-derivat
GB0501192D0 (en) *	2005-01-20	2005-03-02	Resolution Chemicals Ltd	Stable prostaglandin-containing compositions
PT1905453E (pt) *	2005-07-13	2012-12-04	Santen Pharmaceutical Co Ltd	Composição conservante para utilização oftálmica
US8030349B2 (en) *	2005-08-02	2011-10-04	Santen Pharmaceutical Co., Ltd.	Method for prevention of degradation of thermally unstable medicament
CN101282714B (zh)	2005-10-10	2012-12-12	诺瓦加利制药公司	包含前列腺素的眼用乳剂
FI126233B (sv)	2006-02-23	2016-08-31	Oy Kwh Mirka Ab	Oscillerande slipmaskin
FR2918891B1 (fr)	2007-07-20	2009-09-25	Thea Sa Lab	Solution ophtalmique a base de prostaglandines sans conservateur
KR100927617B1 (ko)	2007-11-26	2009-11-23	한국표준과학연구원	열분해 탄소 성분의 나노 크기를 가지는 바이오 센서의감지부를 제작하는 방법
EP2127638A1 (en) *	2008-05-30	2009-12-02	Santen Pharmaceutical Co., Ltd	Method and composition for treating ocular hypertension and glaucoma

2008
- 2008-05-30 EP EP08397513A patent/EP2127638A1/en not_active Withdrawn
2009
- 2009-05-19 TW TW098116503A patent/TWI432202B/zh active
- 2009-05-27 JO JOP/2009/0192A patent/JO3039B1/ar active
- 2009-05-28 AU AU2009252210A patent/AU2009252210C1/en not_active Ceased
- 2009-05-28 SI SI200931694T patent/SI2772249T1/sl unknown
- 2009-05-28 PT PT201646023T patent/PT3714877T/pt unknown
- 2009-05-28 PT PT170004402T patent/PT3205334T/pt unknown
- 2009-05-28 EP EP21217057.5A patent/EP4035656B1/en active Active
- 2009-05-28 SI SI200932073T patent/SI3205334T1/sl unknown
- 2009-05-28 DK DK14001862.3T patent/DK2772249T3/en active
- 2009-05-28 UA UAA201015619A patent/UA102257C2/uk unknown
- 2009-05-28 PT PT97548648T patent/PT2306977E/pt unknown
- 2009-05-28 LT LTEP17000440.2T patent/LT3205334T/lt unknown
- 2009-05-28 ES ES09754864.8T patent/ES2495316T3/es active Active
- 2009-05-28 PL PL17000440T patent/PL3205334T3/pl unknown
- 2009-05-28 HU HUE17000440A patent/HUE049923T2/hu unknown
- 2009-05-28 EA EA201071413A patent/EA023661B1/ru unknown
- 2009-05-28 LT LTEP20164602.3T patent/LT3714877T/lt unknown
- 2009-05-28 KR KR1020207014211A patent/KR102246598B1/ko active Active
- 2009-05-28 PT PT140018623T patent/PT2772249T/pt unknown
- 2009-05-28 DK DK20164602.3T patent/DK3714877T3/da active
- 2009-05-28 ES ES21217057T patent/ES2968837T3/es active Active
- 2009-05-28 ES ES20164602T patent/ES2907982T3/es active Active
- 2009-05-28 EP EP17000440.2A patent/EP3205334B1/en not_active Revoked
- 2009-05-28 SG SG2013041751A patent/SG191628A1/en unknown
- 2009-05-28 HU HUE14001862A patent/HUE033103T2/en unknown
- 2009-05-28 KR KR1020107029072A patent/KR101650006B1/ko active Active
- 2009-05-28 CA CA2724194A patent/CA2724194C/en active Active
- 2009-05-28 ES ES14001862.3T patent/ES2627837T3/es active Active
- 2009-05-28 PL PL14001862T patent/PL2772249T3/pl unknown
- 2009-05-28 US US12/995,351 patent/US9999593B2/en active Active
- 2009-05-28 PL PL20164602T patent/PL3714877T3/pl unknown
- 2009-05-28 DK DK17000440.2T patent/DK3205334T3/da active
- 2009-05-28 DK DK09754864.8T patent/DK2306977T3/da active
- 2009-05-28 HR HRP20220361TT patent/HRP20220361T1/hr unknown
- 2009-05-28 EP EP25150453.6A patent/EP4512424B1/en active Active
- 2009-05-28 BR BRPI0913109A patent/BRPI0913109B8/pt not_active IP Right Cessation
- 2009-05-28 EP EP20164602.3A patent/EP3714877B1/en not_active Revoked
- 2009-05-28 KR KR1020187001130A patent/KR101988642B1/ko active Active
- 2009-05-28 MX MX2010012987A patent/MX2010012987A/es active IP Right Grant
- 2009-05-28 CA CA2965185A patent/CA2965185A1/en not_active Abandoned
- 2009-05-28 KR KR1020197016340A patent/KR102114401B1/ko active Active
- 2009-05-28 HU HUE20164602A patent/HUE058079T2/hu unknown
- 2009-05-28 GE GEAP200912045A patent/GEP20156220B/en unknown
- 2009-05-28 MY MYPI2010005463A patent/MY159463A/en unknown
- 2009-05-28 KR KR1020167022210A patent/KR101820816B1/ko active Active
- 2009-05-28 EP EP23202597.3A patent/EP4289446B1/en active Active
- 2009-05-28 SI SI200931050T patent/SI2306977T1/sl unknown
- 2009-05-28 ES ES25150453T patent/ES3069010T3/es active Active
- 2009-05-28 AR ARP090101912A patent/AR071937A1/es not_active Application Discontinuation
- 2009-05-28 CN CN2009801197245A patent/CN102083413B/zh active Active
- 2009-05-28 LT LTEP14001862.3T patent/LT2772249T/lt unknown
- 2009-05-28 ES ES23202597T patent/ES3014089T3/es active Active
- 2009-05-28 EP EP14001862.3A patent/EP2772249B1/en not_active Revoked
- 2009-05-28 EP EP09754864.8A patent/EP2306977B1/en active Active
- 2009-05-28 PL PL09754864T patent/PL2306977T3/pl unknown
- 2009-05-28 JP JP2011511256A patent/JP2011521943A/ja active Pending
- 2009-05-28 WO PCT/JP2009/060211 patent/WO2009145356A1/en not_active Ceased
- 2009-05-28 SI SI200932159T patent/SI3714877T1/sl unknown
- 2009-05-28 HR HRP20140979AT patent/HRP20140979T1/hr unknown
- 2009-05-28 ES ES17000440T patent/ES2808050T3/es active Active
2014
- 2014-04-22 JP JP2014088256A patent/JP2014133765A/ja active Pending
- 2014-09-18 CY CY20141100763T patent/CY1115565T1/el unknown
2015
- 2015-12-07 JP JP2015238594A patent/JP6148317B2/ja active Active
2017
- 2017-05-18 JP JP2017098843A patent/JP6356868B2/ja active Active
- 2017-05-23 HR HRP20170769TT patent/HRP20170769T1/hr unknown
- 2017-06-27 CY CY20171100675T patent/CY1120351T1/el unknown
2018
- 2018-06-14 JP JP2018113647A patent/JP6649992B2/ja active Active
- 2018-06-18 US US16/010,739 patent/US10864159B2/en active Active
- 2018-11-01 AR ARP180103181A patent/AR120961A2/es not_active Application Discontinuation
2020
- 2020-01-17 JP JP2020005799A patent/JP6889789B2/ja active Active
- 2020-06-24 HR HRP20200998TT patent/HRP20200998T1/hr unknown
- 2020-11-11 US US17/094,986 patent/US20210059931A1/en not_active Abandoned
2021
- 2021-05-21 JP JP2021085839A patent/JP7265584B2/ja active Active
2023
- 2023-04-14 JP JP2023066348A patent/JP7520285B2/ja active Active
2024
- 2024-04-12 JP JP2024064531A patent/JP2024079852A/ja active Pending

Also Published As

Publication number	Publication date
HUE058079T2 (hu)	2022-06-28
SI2306977T1 (sl)	2014-12-31
SI3205334T1 (sl)	2020-10-30
SI3714877T1 (sl)	2022-05-31
DK3714877T3 (da)	2022-02-14
JP6148317B2 (ja)	2017-06-14
KR20160102319A (ko)	2016-08-29
PT3205334T (pt)	2020-07-31
US20110152264A1 (en)	2011-06-23
AU2009252210A1 (en)	2009-12-03
KR101650006B1 (ko)	2016-08-22
EP4289446A2 (en)	2023-12-13
KR20200057801A (ko)	2020-05-26
PT2772249T (pt)	2017-08-08
BRPI0913109B8 (pt)	2021-05-25
CY1115565T1 (el)	2017-01-04
HUE033103T2 (en)	2017-11-28
EP4512424A2 (en)	2025-02-26
PL3714877T3 (pl)	2022-05-16
DK2772249T3 (en)	2017-07-17
JP6889789B2 (ja)	2021-06-18
EP3714877B1 (en)	2022-01-26
ES2495316T3 (es)	2014-09-17
ES2627837T3 (es)	2017-07-31
CA2724194C (en)	2017-06-27
EA023661B1 (ru)	2016-06-30
MY159463A (en)	2017-01-13
TWI432202B (zh)	2014-04-01
JP2011521943A (ja)	2011-07-28
JP2021120412A (ja)	2021-08-19
ES2627837T8 (es)	2018-02-26
JO3039B1 (ar)	2016-09-05
EP4289446A3 (en)	2024-01-10
DK2306977T3 (da)	2014-09-15
EP4035656A1 (en)	2022-08-03
WO2009145356A1 (en)	2009-12-03
EP2127638A1 (en)	2009-12-02
EP4035656B1 (en)	2023-11-22
EP2306977A1 (en)	2011-04-13
ES2808050T3 (es)	2021-02-25
JP2024079852A (ja)	2024-06-11
ES3069010T3 (en)	2026-06-03
EP2306977B1 (en)	2014-08-13
EP3205334A1 (en)	2017-08-16
JP6649992B2 (ja)	2020-02-19
EP4512424B1 (en)	2026-03-18
DK3205334T3 (da)	2020-07-13
EP2772249B1 (en)	2017-05-03
HRP20200998T1 (hr)	2020-10-16
EP2772249A1 (en)	2014-09-03
AR120961A2 (es)	2022-04-06
PT3714877T (pt)	2022-03-10
PL3205334T3 (pl)	2020-11-02
EA201071413A1 (ru)	2011-06-30
KR20110011707A (ko)	2011-02-08
EP4512424A3 (en)	2025-03-05
HUE049923T2 (hu)	2020-11-30
US9999593B2 (en)	2018-06-19
SG191628A1 (en)	2013-07-31
BRPI0913109A2 (pt)	2017-06-20
JP2023085558A (ja)	2023-06-20
BRPI0913109B1 (pt)	2019-10-22
AR071937A1 (es)	2010-07-28
EP3205334B1 (en)	2020-04-29
PL2772249T3 (pl)	2017-10-31
ES3014089T3 (en)	2025-04-16
TW201000104A (en)	2010-01-01
HRP20170769T1 (hr)	2017-08-11
JP2020073574A (ja)	2020-05-14
HRP20140979T1 (hr)	2014-11-21
AU2009252210B2 (en)	2014-10-16
LT3714877T (lt)	2022-04-11
KR101988642B1 (ko)	2019-06-12
CA2965185A1 (en)	2009-12-03
EP4289446B1 (en)	2025-02-12
KR102114401B1 (ko)	2020-05-25
HRP20220361T1 (hr)	2022-05-13
JP2018154656A (ja)	2018-10-04
KR20180008905A (ko)	2018-01-24
JP2016065095A (ja)	2016-04-28
PT2306977E (pt)	2014-09-22
JP2017178957A (ja)	2017-10-05
US20180289618A1 (en)	2018-10-11
CN102083413B (zh)	2013-11-06
KR20190067272A (ko)	2019-06-14
ES2968837T3 (es)	2024-05-14
KR101820816B1 (ko)	2018-01-22
PL2306977T3 (pl)	2015-01-30
CA2724194A1 (en)	2009-12-03
JP2014133765A (ja)	2014-07-24
LT2772249T (lt)	2017-09-11
ES2907982T3 (es)	2022-04-27
SI2772249T1 (sl)	2017-08-31
KR102246598B1 (ko)	2021-04-30
AU2009252210C1 (en)	2016-04-14
CY1120351T1 (el)	2019-07-10
UA102257C2 (uk)	2013-06-25
MX2010012987A (es)	2011-02-24
US10864159B2 (en)	2020-12-15
GEP20156220B (en)	2015-01-26
JP7520285B2 (ja)	2024-07-23
JP6356868B2 (ja)	2018-07-11
JP7265584B2 (ja)	2023-04-26
CN102083413A (zh)	2011-06-01
US20210059931A1 (en)	2021-03-04
EP3714877A1 (en)	2020-09-30

Publication	Publication Date	Title
LT3714877T (lt)	2022-04-11	Būdas ir kompozicija, skirti akių hipertenzijai ir glaukomai gydyti
LT2894165T (lt)	2023-03-10	Būdai ir kompozicijos, skirti su komplementu susijusių sutrikimų gydymui
BRPI1007477A2 (pt)	2016-02-16	método, e, composição de tratamento de poço
BRPI0919575A2 (pt)	2017-03-28	método, e, composição
BRPI0823277A2 (pt)	2015-06-23	Composição, e , método
BRPI0814941A2 (pt)	2014-09-30	Composição de tratamentode semente, e, método de tratamento de semente.
CY2016017I2 (el)	2016-10-05	Συνθεση για θεραπεια πνευμονικης υπερτασης
HUE049880T2 (hu)	2020-10-28	Anyag és eljárások Her-3-mal összefüggõ betegségek kezelésére vagy megelõzésére
BRPI0910854A2 (pt)	2015-10-06	métodos de tratamento
BRPI0920284A2 (pt)	2016-08-02	composição e método
BRPI0913227A2 (pt)	2016-01-19	método, e objeto
EP2288365A4 (en)	2012-05-09	TARGETED COOLING FACTORS AND METHOD OF APPLICATION THEREFOR
PL3476371T3 (pl)	2022-09-19	Urządzenie do leczenia gerd
HUE036780T2 (hu)	2018-07-30	Új kompozíciók és eljárások immunológiai vonatkozású betegségek kezelésére
BRPI0809573A2 (pt)	2016-07-26	composição, e, método
PL2338519T3 (pl)	2016-06-30	Środek do leczenia zwłóknienia szpiku
PL3133396T3 (pl)	2019-03-29	Sposób leczenia z zastosowaniem leków wychwytujących amoniak
BRPI0908635A2 (pt)	2015-10-13	composto, composição farmacêutica e método de tratamento de câncer
BRPI0814167A2 (pt)	2015-01-20	Composição, e, método
IL207397A0 (en)	2010-12-30	Difluorobiphenylamide derivtives for the treatment of ocular hypertension
BRPI0822472A2 (pt)	2015-06-16	Método, camundongo, e, composição
BRPI0823238A2 (pt)	2015-06-16	Composição, e, método
BRPI0820644A2 (pt)	2018-07-10	método de preparação de uma composição, e, composição
DK2321359T3 (da)	2012-10-15	Fremgangsmåde til behandling af naturlige gummiprodukter
BRPI0822129A2 (pt)	2015-06-23	Inibidores de aldh-2c no tratamento de vício.